Report Detail

Request for Sample of this report

Pharma & Healthcare Global Ivermectin Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4672881
    • |
  • 16 February, 2026
    • |
  • Global
    • |
  • 121 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Ivermectin Tablets market size was valued at US$ 581 million in 2025 and is forecast to a readjusted size of US$ 728 million by 2032 with a CAGR of 3.3% during review period.
Ivermectin is used to treat river blindness (onchocerciasis), intestinal infection from threadworms (strongyloidiasis), and other kinds of worm infections. Ivermectin is an anthelmintic. It works by interfering with the nerve and muscle functions of worms, by paralyzing and killing them.
Global ivermectin tablet production is projected to reach 1.13 billion tablets by 2025, with an average price of US$0.50 per tablet. Gross profit margins typically range from 25% to 40%.
The upstream of the ivermectin tablet industry chain mainly includes the fermentation and chemical synthesis of the active pharmaceutical ingredient (API) ivermectin, excipients, and pharmaceutical packaging materials. Among these, the cost and quality consistency of the API have the greatest impact on the price and compliance of the finished product. The downstream is the core of the demand side, with applications concentrated in the prevention and treatment of human parasitic diseases, including common parasitic diseases such as intestinal nematode infections, scabies, and head lice. The main usage scenarios are hospitals, primary healthcare institutions, pharmacies, and public health projects. In developing countries and tropical regions, this product is widely included in government or international organization-led disease control programs, characterized by large-scale centralized procurement and long-term stable usage. Downstream users are highly price-sensitive but have strict requirements for supply stability and quality standards. In some mature markets, ivermectin is more often used as a prescription drug or for specific indications, with relatively stable demand but limited growth.
The overall industry development trend is characterized by a differentiated demand structure. Public health and centralized procurement channels maintain large-volume, low-price supply, while retail and hospital sectors focus more on dosage accuracy and compliant labeling. Key driving factors include the long-term presence of parasitic diseases in some regions, the continued advancement of public health prevention and control projects, and improved accessibility of generic drugs. The main obstacles are: patents having expired long ago leading to severe homogenization; intense price competition; stricter regulations on ivermectin's indications in some markets; and public opinion and controversies surrounding its use outside of indications causing fluctuations in demand expectations.
This report is a detailed and comprehensive analysis for global Ivermectin Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ivermectin Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
Global Ivermectin Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
Global Ivermectin Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
Global Ivermectin Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Tablets), and ASP (US$/Tablet), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ivermectin Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ivermectin Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck (MSD), Teva, Orion, Substipharm, Medical Valley Invest, Galenicum Derma, Centrafarm, Laboratorios Liconsa, Vygoris, Exeltis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ivermectin Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
0.2mg
0.5mg
1mg
2mg
3mg
6mg
12mg
Market segment by Dosage Form
Plain Tablets
Dispersible Tablets
Chewable Tablets
Enteric-Coated Tablets
Sustained-Release Tablets
Coated Tablets
Market segment by Purity
More than 99%
98%-99%
95%-98%
Market segment by Application
Livestock
Poultry
Pets
Wild Animals
Major players covered
Merck (MSD)
Teva
Orion
Substipharm
Medical Valley Invest
Galenicum Derma
Centrafarm
Laboratorios Liconsa
Vygoris
Exeltis
Zydus UK
Dr. Reddy's Laboratories
Edenbridge Pharmaceuticals
Advagen Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ivermectin Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ivermectin Tablets, with price, sales quantity, revenue, and global market share of Ivermectin Tablets from 2021 to 2026.
Chapter 3, the Ivermectin Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ivermectin Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ivermectin Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ivermectin Tablets.
Chapter 14 and 15, to describe Ivermectin Tablets sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ivermectin Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 0.2mg
    • 1.3.3 0.5mg
    • 1.3.4 1mg
    • 1.3.5 2mg
    • 1.3.6 3mg
    • 1.3.7 6mg
    • 1.3.8 12mg
  • 1.4 Market Analysis by Dosage Form
    • 1.4.1 Overview: Global Ivermectin Tablets Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
    • 1.4.2 Plain Tablets
    • 1.4.3 Dispersible Tablets
    • 1.4.4 Chewable Tablets
    • 1.4.5 Enteric-Coated Tablets
    • 1.4.6 Sustained-Release Tablets
    • 1.4.7 Coated Tablets
  • 1.5 Market Analysis by Purity
    • 1.5.1 Overview: Global Ivermectin Tablets Consumption Value by Purity: 2021 Versus 2025 Versus 2032
    • 1.5.2 More than 99%
    • 1.5.3 98%-99%
    • 1.5.4 95%-98%
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Ivermectin Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Livestock
    • 1.6.3 Poultry
    • 1.6.4 Pets
    • 1.6.5 Wild Animals
  • 1.7 Global Ivermectin Tablets Market Size & Forecast
    • 1.7.1 Global Ivermectin Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Ivermectin Tablets Sales Quantity (2021-2032)
    • 1.7.3 Global Ivermectin Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Merck (MSD)
    • 2.1.1 Merck (MSD) Details
    • 2.1.2 Merck (MSD) Major Business
    • 2.1.3 Merck (MSD) Ivermectin Tablets Product and Services
    • 2.1.4 Merck (MSD) Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Merck (MSD) Recent Developments/Updates
  • 2.2 Teva
    • 2.2.1 Teva Details
    • 2.2.2 Teva Major Business
    • 2.2.3 Teva Ivermectin Tablets Product and Services
    • 2.2.4 Teva Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Teva Recent Developments/Updates
  • 2.3 Orion
    • 2.3.1 Orion Details
    • 2.3.2 Orion Major Business
    • 2.3.3 Orion Ivermectin Tablets Product and Services
    • 2.3.4 Orion Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Orion Recent Developments/Updates
  • 2.4 Substipharm
    • 2.4.1 Substipharm Details
    • 2.4.2 Substipharm Major Business
    • 2.4.3 Substipharm Ivermectin Tablets Product and Services
    • 2.4.4 Substipharm Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Substipharm Recent Developments/Updates
  • 2.5 Medical Valley Invest
    • 2.5.1 Medical Valley Invest Details
    • 2.5.2 Medical Valley Invest Major Business
    • 2.5.3 Medical Valley Invest Ivermectin Tablets Product and Services
    • 2.5.4 Medical Valley Invest Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Medical Valley Invest Recent Developments/Updates
  • 2.6 Galenicum Derma
    • 2.6.1 Galenicum Derma Details
    • 2.6.2 Galenicum Derma Major Business
    • 2.6.3 Galenicum Derma Ivermectin Tablets Product and Services
    • 2.6.4 Galenicum Derma Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Galenicum Derma Recent Developments/Updates
  • 2.7 Centrafarm
    • 2.7.1 Centrafarm Details
    • 2.7.2 Centrafarm Major Business
    • 2.7.3 Centrafarm Ivermectin Tablets Product and Services
    • 2.7.4 Centrafarm Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Centrafarm Recent Developments/Updates
  • 2.8 Laboratorios Liconsa
    • 2.8.1 Laboratorios Liconsa Details
    • 2.8.2 Laboratorios Liconsa Major Business
    • 2.8.3 Laboratorios Liconsa Ivermectin Tablets Product and Services
    • 2.8.4 Laboratorios Liconsa Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Laboratorios Liconsa Recent Developments/Updates
  • 2.9 Vygoris
    • 2.9.1 Vygoris Details
    • 2.9.2 Vygoris Major Business
    • 2.9.3 Vygoris Ivermectin Tablets Product and Services
    • 2.9.4 Vygoris Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Vygoris Recent Developments/Updates
  • 2.10 Exeltis
    • 2.10.1 Exeltis Details
    • 2.10.2 Exeltis Major Business
    • 2.10.3 Exeltis Ivermectin Tablets Product and Services
    • 2.10.4 Exeltis Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Exeltis Recent Developments/Updates
  • 2.11 Zydus UK
    • 2.11.1 Zydus UK Details
    • 2.11.2 Zydus UK Major Business
    • 2.11.3 Zydus UK Ivermectin Tablets Product and Services
    • 2.11.4 Zydus UK Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Zydus UK Recent Developments/Updates
  • 2.12 Dr. Reddy's Laboratories
    • 2.12.1 Dr. Reddy's Laboratories Details
    • 2.12.2 Dr. Reddy's Laboratories Major Business
    • 2.12.3 Dr. Reddy's Laboratories Ivermectin Tablets Product and Services
    • 2.12.4 Dr. Reddy's Laboratories Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Dr. Reddy's Laboratories Recent Developments/Updates
  • 2.13 Edenbridge Pharmaceuticals
    • 2.13.1 Edenbridge Pharmaceuticals Details
    • 2.13.2 Edenbridge Pharmaceuticals Major Business
    • 2.13.3 Edenbridge Pharmaceuticals Ivermectin Tablets Product and Services
    • 2.13.4 Edenbridge Pharmaceuticals Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Edenbridge Pharmaceuticals Recent Developments/Updates
  • 2.14 Advagen Pharma
    • 2.14.1 Advagen Pharma Details
    • 2.14.2 Advagen Pharma Major Business
    • 2.14.3 Advagen Pharma Ivermectin Tablets Product and Services
    • 2.14.4 Advagen Pharma Ivermectin Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Advagen Pharma Recent Developments/Updates

3 Competitive Environment: Ivermectin Tablets by Manufacturer

  • 3.1 Global Ivermectin Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Ivermectin Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Ivermectin Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Ivermectin Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Ivermectin Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Ivermectin Tablets Manufacturer Market Share in 2025
  • 3.5 Ivermectin Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Ivermectin Tablets Market: Region Footprint
    • 3.5.2 Ivermectin Tablets Market: Company Product Type Footprint
    • 3.5.3 Ivermectin Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ivermectin Tablets Market Size by Region
    • 4.1.1 Global Ivermectin Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Ivermectin Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Ivermectin Tablets Average Price by Region (2021-2032)
  • 4.2 North America Ivermectin Tablets Consumption Value (2021-2032)
  • 4.3 Europe Ivermectin Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Ivermectin Tablets Consumption Value (2021-2032)
  • 4.5 South America Ivermectin Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Ivermectin Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Ivermectin Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Ivermectin Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Ivermectin Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Ivermectin Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Ivermectin Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Ivermectin Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Ivermectin Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Ivermectin Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Ivermectin Tablets Market Size by Country
    • 7.3.1 North America Ivermectin Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Ivermectin Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Ivermectin Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Ivermectin Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Ivermectin Tablets Market Size by Country
    • 8.3.1 Europe Ivermectin Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Ivermectin Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ivermectin Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Ivermectin Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Ivermectin Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Ivermectin Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Ivermectin Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Ivermectin Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Ivermectin Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Ivermectin Tablets Market Size by Country
    • 10.3.1 South America Ivermectin Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Ivermectin Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ivermectin Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Ivermectin Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Ivermectin Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Ivermectin Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Ivermectin Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Ivermectin Tablets Market Drivers
  • 12.2 Ivermectin Tablets Market Restraints
  • 12.3 Ivermectin Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ivermectin Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ivermectin Tablets
  • 13.3 Ivermectin Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ivermectin Tablets Typical Distributors
  • 14.3 Ivermectin Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Ivermectin Tablets. Industry analysis & Market Report on Ivermectin Tablets is a syndicated market report, published as Global Ivermectin Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Ivermectin Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo